key: cord-0928068-nr5vkqa2 authors: Clark, C.; Schrecker, J.; Hardison, M.; Taitel, M. S. title: Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 Variants date: 2022-04-19 journal: nan DOI: 10.1101/2022.04.18.22273989 sha: 5c167d2fa5cf855e25b9136c4dc50486ad6bab03 doc_id: 928068 cord_uid: nr5vkqa2 SARS-CoV-2, the virus that causes COVID-19, has many variants capable of rapid transmission causing serious illness. Timely surveillance of new variants is essential for an effective public health response. Ensuring availability and access to diagnostic and molecular testing is key to this type of surveillance. This study utilized reverse transcription polymerase chain reaction (RT-PCR) and whole genome sequencing results from COVID-19-positive patient samples obtained through a collaboration between Aegis Sciences Corporation and Walgreens Pharmacy that has conducted more than 8.5 million COVID-19 tests at ~5,200 locations across the United States and Puerto Rico. Viral evolution of SARS-CoV-2 can lead to mutations in the S-gene that cause reduced or failed S-gene amplification in diagnostic PCR tests. These anomalies, labeled reduced S-gene target performance (rSGTP) and S-gene target failure (SGTF), are characteristic of Alpha and Omicron (B.1.1.529, BA.1, and BA.1.1) lineages. This observation has been validated by whole genome sequencing and can provide presumptive lineage data following completion of diagnostic PCR testing in 24-48 hours from collection. Active surveillance of trends in PCR and sequencing results is key to the identification of changes in viral transmission and emerging variants. This study shows that rSGTP and SGTF can be utilized for near real-time tracking and surveillance of SARS-CoV-2 variants. Surveillance data of circulating variants are typically available 2 weeks after the date of specimen collection due to the length of time required to complete whole genome sequencing. Efforts have been made to optimize sequencing methods and validate other methods to track the spread of viral lineages more efficiently. Some variants, such as Alpha and Omicron Although the use of SGTF for rapid surveillance of viral spread has been reported in peerreviewed literature, the rates of transmission are likely underreported based on analysis of SGTF alone (8) . This manuscript describes the validation of reduced S-gene target performance (rSGTP) analysis in addition to SGTF for early surveillance of variants with characteristic Sgene mutations, like del69-70. The use of additional measures for rapid surveillance of variants with rSGTP and SGTF allow for a real-time assessment of transmission and assist with identification of emerging variants during periods of transition. Herein we show the use of a novel algorithm for rSGTP and SGTF based on the Ct values of the RT-PCR results as a proxy to rapidly assess the spread of certain SARS-CoV-2 lineages and validation of the algorithm with sequencing results in a randomized subset of specimens. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022 This study describes SARS-CoV-2 RT-PCR and whole genome sequencing results obtained via a collaboration between Aegis Sciences Corporation and Walgreens Pharmacy that has CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Lineages identified in these samples were: Alpha -8.40% (n = 31,442), Delta -60.15% . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022 SARS-CoV-2 genomes accumulate ~2 mutations per month, and over time, viral evolution gives rise to new lineages that are partitioned into phylogenetic trees and classified as variant strains (11) . Mutations in variants of concern (VOC), such as Omicron and previously Alpha, pose a challenge for some PCR primers to anneal to the S-gene. The phenomenon defined as reduced S-gene target performance (rSGTP) and failure (SGTF) is characteristic of both Alpha and is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273989 doi: medRxiv preprint rSGTP and SGTF as a proxy for surveillance of Omicron and other variants of concern with these characteristic PCR result patterns, significantly accelerates the ability to identify changes in viral spread versus an additional week or more necessary for viral genome sequencing. Several previous publications have reported similar mechanisms for utilizing SGTF to increase efficiency of surveillance of certain variants of concern. To date, the publications have primarily CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273989 doi: medRxiv preprint only during a time at which Alpha was in circulation (19) . These investigators labeled samples with reduced S-gene amplification in comparison to that of N and ORF1ab-genes as "S-gene target late detection," or SGTL. More specifically, these samples were identified when S-gene Ct values were ≥ 5 cycles higher than N or ORF1ab-genes and were reported as totaling less than 1% of all Alpha cases. Our analysis defined samples as having rSGTP when the S-gene cycle threshold value was at least 4 cycles higher than the average Ct values of N and ORF1ab, and nearly 17% of Alpha and 8% of Omicron B.1.1.529/BA.1/BA.1.1 cases exhibited rSGTP. As we endure an ever-changing pandemic, the development of novel tools to both diagnose acute infections and to expedite identification of emerging variants will be critical during the transition into an endemic phase. Collaborative efforts between laboratories and healthcare providers to identify unique trends within large, shared datasets can provide support for public health decision making. Those engaged in protecting public health during the COVID-19 pandemic are urged to adopt new methods to identify and track this virus as it continues to mutate. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022 Normal S-gene Amplification SGTF rSGTP . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273989 doi: medRxiv preprint Date range truncated at March 2021 due to low sample volume for sequenced samples prior to this date . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273989 doi: medRxiv preprint SARS-CoV-2 lineages. Pango Lineages Website Different Strategies for the Identification of SARS-CoV-2 Variants in the Laboratory Practice Tracking SARS-CoV-2 Variants. World Health Organization Website SARS-CoV-2 Variant Classifications and Definitions. Centers for Disease Control and Prevention Website Omicron and S-gene target failure cases in the highest COVID-19 case rate region in Canada Morbidity and Mortality Weekly Report (MMWR) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data Surveillance and epidemiology of SARS-CoV-2 viral variants in the United States ThermoFisher Scientific. TaqPath™ COVID-19 Combo Kit and TaqPath™ Combo Kit Advanced INSTRUCTIONS FOR USE: Multiplex real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 COVID-19 Geonomics UK (COG-UK) Consortium, Peacock SJ, Robertson DL. SARS-CoV-2 variants, spike mutations and immune escape Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data Tracking the Initial Diffusion of SARS-CoV-2 Omicron Variant in Italy by RT-PCR and Comparison with Alpha and Delta Variants Spreading. Diagnostics (Basel) Increased risk of infection with SARS-CoV-2 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study Omicron and S-gene target failure cases in the highest COVID-19 case rate region in Canada Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity